Maryland FQHC Intelligence

HSCRC says AHEAD requires statewide all-payer total-cost growth and primary-care investment targets. A short-term advisory council informed the methodology, and the Regulatory Working Group is accepting comments on its draft recommendation through July 20, 2026.

The public page confirms the target-setting process and comment window but does not support the previously attached $2-per-member payment, 250-patient threshold, or FQHC PPS claims.

MDH's employer guidance says some Medicaid members will face work and renewal requirements beginning in January 2027, with lower-wage, part-time and seasonal workers more likely to be affected. Employers can distribute official toolkit materials and direct employees to Maryland Health Connection, but they are not expected to determine Medicaid eligibility.

This creates a bounded outreach role for health-center employers and community partners without transferring eligibility decisions to them.

The live Rural Health Transformation schedule lists two Maryland Department of Labor opportunities posted July 10 through August 9, 2026: $3.5 million for apprenticeship and Rural Advancement for Maryland Peers expansion, and $15 million for pipeline training plus provider training, recruitment and retention. These are components of the workforce pillar, not unrestricted grants to every health center.

Potential applicants must verify eligibility and terms in the linked procurement records.

MDH's July 10 implementation page reports an exact first-year Rural Health Transformation award of $168,180,837.61, fully funded by CMS/HHS and renewable over five years for 18 state-designated rural areas. Budget Period 1 includes $163.7 million in subawards, of which $134.8 million is available through competitive procurement, across workforce, sustainable access and innovative care, and healthy-food initiatives.

The page does not state the previously reported October 2026 obligation deadline.

CCI Health Services welcomed four inaugural family-medicine residents on July 1, 2026 at its Greenbelt health center. CCI reports that its 2024 ACGME accreditation made it the first Maryland FQHC accredited to sponsor a community-based family-medicine residency; the program lasts three years and includes partner clinical sites.

This confirms the initial cohort, not the 12-resident scale or unrelated site expansions previously attached to the claim.

The Maryland Insurance Administration reported proposed rates affecting about 482,000 people across individual non-Medigap health, small-group health, and individual non-Medigap stand-alone dental products, equal to 19% of the commercial market. Requested averages are 13.7% in the individual non-Medigap health market and 13.1% in small-group health; MIA links individual-market pressure to expired enhanced credits while state assistance continues in 2027 at a level still to be determined.

Rates remain under actuarial review, with a future public hearing on July 23, written filing comments through August 28, and decisions expected in September.

On June 26, the state announced $96.3 million in Community Health Resources Commission grants for clinical and nonclinical behavioral-health supports during the 2026-27 school year. The consortium program is operating in 84% of Maryland schools, the new awards are projected to serve about 200,000 children, and more than 500 behavioral-health workers have been hired.

The release covers awards statewide but does not identify the portion, if any, flowing specifically to FQHCs.

A May 28 order states that a majority of eligible active Fourth Circuit judges voted to grant rehearing en banc in the consolidated Maryland appeals led by No. 24-1939. The court directed additional paper copies of the existing briefs and scheduled argument for the next available court session.

The two-page order grants rehearing but does not decide whether Maryland's statute is valid or specify the ultimate availability of contract-pharmacy protections.

MHCC's May funding notice offered up to 15 one-year grants, capped at $1.6 million each, to establish or expand advanced primary care in Maryland's designated rural areas. Existing or new primary-care practices, FQHCs, and organizations prepared to sponsor a practice were eligible; applications were due June 1.

The competitive notice establishes eligibility and program design, not an award to every applicant.

The primary-care RFA sets an anticipated grant period of August 1, 2026 through September 30, 2027 for the approximately $6.3 million program. It says one-time awards must be fully expended by the end date with no extensions, and FQHCs are eligible alongside primary-care practices and sponsoring organizations.

August 1 is a proposed program start in the solicitation, not proof that awards had been executed or services had launched by July 15.

The April 14 panel opinion applied the Fourth Circuit's West Virginia precedent, held that the Maryland district court had erred as a matter of law, and vacated and remanded the order denying a preliminary injunction. It left the district court to determine preliminary relief in the first instance; one judge dissented.

Because the full court later granted en banc rehearing, readers should not present this panel disposition as the final appellate resolution.

In March 25 Senate Finance testimony, MACHC supported HB 1112 and described Maryland's 16 FQHCs as facing workforce shortages, rising operating costs and greater patient acuity. MACHC asked the proposed study to examine sustainable mechanisms, including targeted safety-net grants, and offered to provide data and stakeholder input.

This is an advocacy position submitted in committee testimony, not evidence that the bill was enacted or that funding was appropriated.

The FY2026 Community Health Resources Commission RFA made approximately $7 million available for projects lasting up to three years. FQHCs and look-alikes are designated eligible community health resources if they meet sliding-fee and other regulatory requirements; six areas include hospital-community partnerships, vulnerable populations, chronic disease, dental care, Medicaid dental access and adult behavioral health.

AHEAD alignment is one strategic consideration, but this is a CHRC annual competition rather than an AHEAD-only grant; letters of intent and full applications were due March 30 and April 23.

Maryland Health Benefit Exchange reported 255,612 plan selections for the 2026 open-enrollment period, up 3%, after enhanced federal credits expired. State premium assistance replaced some or all expired help for people below 400% of poverty, with the most help below 200%; young-adult enrollment rose 7%.

Stress signals remain: 5,743 people shifted from gold to bronze plans, new enrollment fell 12%, and about 18,000 lawfully present immigrants below poverty lost advance-credit eligibility on January 1.

MDH says Maryland transitioned to AHEAD on January 1, 2026 and that the existing Maryland Primary Care Program continues with no current changes. The state's primary-care architecture includes an infrastructure pathway, Medicare options through MDPCP-AHEAD or PC AHEAD, and a Medicaid pathway.

The page establishes continuity and program structure but does not guarantee that every FQHC participates or receives a specific payment.

MDH announced on December 31, 2025 that Maryland received $168 million for the first year of the five-year Rural Health Transformation Program, renewable over five years. The approved direction covers workforce pipelines, sustainable access and innovative care, technology, and food infrastructure and nutrition.

The release says implementation details were still under discussion with CMS, so later state procurement pages control current amounts and application windows.

CMS's current model page identifies Maryland in Cohort 1 and sets December 31, 2035 as the end date for all cohorts, correcting the former 2034 date. AHEAD combines cooperative-agreement funding, Primary Care AHEAD, hospital global budgets and geographic accountable entities.

Participating primary-care practices may receive prospective risk-adjusted enhanced payments with quality adjustments and multiple payment pathways, subject to participation terms.

The General Assembly record shows HB 1056 became Chapter 962 after gubernatorial approval on May 16, 2024 and took effect July 1, 2024. The statute prohibits a 340B manufacturer from directly or indirectly limiting or restricting acquisition or delivery of a 340B drug, treats violations as unfair or deceptive trade practices, and required a Prescription Drug Affordability Board study by July 1, 2026.

The current federal litigation concerns enforceability; the legislative record itself does not resolve that litigation.